CClinicalTrials.gg
CompletedNCT05391919Updated Sep 14, 2023

Multimodal Correction of Post-stroke Motor and Cognitive Impairments

An interventional study of Multimodal technology (MT) and Conventional rehabilitation (CR) in Stroke Rehabilitation, sponsored by Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine. Completed at 1 site in Russian Federation. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-09-14.

Sponsored by Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Study summary

The aim of the study is the development and scientific substantiation of the effectiveness and safety of multimodal rehabilitation technology using innovative digital technologies, biofeedback (BFB), virtual reality (VR), neurointerface for the restoration of stato-locomotor disorders, neuromuscular control of upper limb movements and cognitive functions in patients with ischemic stroke (IS) in different recovery periods with rehabilitation risks control in outpatient clinic.

Read the detailed description

The object of the study The study will include 90 patients (men and women) with the diagnosis of ischemic stroke (IS) in the early recovery (up to 6 months) and late recovery (6-12 months) periods with stato-locomotor disturbances, dysfunction (violation of neuromuscular movement control) of the upper limb (UL), mild or moderate cognitive impairment.

Patients will be randomly assigned to one of three experimental groups - 2 main groups in the early (30 patients) and in the late recovery period (30 patients) of IS and 1 comparison group (30 patients) in the early and late recovery periods of IS.

Each participant of the study will be assigned an ordinal number. Patients of the 1st and 2nd main groups are planned to undergo a rehabilitation course with multimodal correction, depending on the severity of functional and neuropsychological disturbances with the use of FBF-stabilometric training, cognitive-motor training with double and triple tasks in a virtual environment, functional individually programmed stimulation of antagonist muscles of the lower limb (FES), training of subject-manipulative activity for the restoration of fine hand movements on the glove simulator "SensoRehab"; when severe and moderate paresis of the upper limb, the neurointerface "Exokist-3" with EEG registration will be used.

The mode of application of multimodal correction technology: 15 procedures, 2-3 times a week, the duration of the course is 5-8 weeks. The total duration of one procedure is 2-3 hours a day.

Multimodal correction technology will not be included in the rehabilitation program of patients in the comparison group.

02

Conditions studied

  • Stroke Rehabilitation

Keywords

  • ischemic stroke rehabilitation
  • post-stroke dysfunction of the hand
  • cognitive disfunction
  • artificial intelligence
  • virtual reality
  • neurointerface
  • smart glove
  • biofeedback
  • cardiology risk control
  • upper limb medical rehabilitation
  • digital interactive technology
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 90 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Men or women aged 45 to 70 years after a first-onset IS, early (1-6 months), late recovery (6-12 months) periods.
  2. Supratentorial IS according to MRI of the brain.
  3. The severity of UL paresis ranged from a score of 4 to 3 according to the Medical Research Council Scale (MRCS).20
  4. Spasticity of 2 points or less by the Modified Ashworth Scale (MAS)
  5. Cognitive function more than 20 points on the Montreal Cognitive Assessment (MoCA)
  6. Affective disorders score less than 11 on the Hospital Anxiety and Depression Scale (HADS)
  7. The patient's ability and willingness to comply with the requirements of this protocol.

Exclusion criteria

Exclusion Criteria:

  1. Concomitant neurological diseases causing decreased muscle strength or increased muscle tone in the UL (e.g., cerebral palsy, brain injury).
  2. Clinically significant limitation of the passive movement amplitude in the joints of the investigated hand, pronounced contracture and deformities of the upper extremity.
  3. Use of other DIT, BFB techniques to restore impaired UL function within 30 days prior to the patient Inclusion Visit.
  4. Severe visual impairment, decreased visual acuity of less than 0.2 in the worst eye according to the Golovin-Sivtsev Table24.
  5. Sensory aphasia, gross motor aphasia.
  6. Recurrent stroke.
  7. Epilepsy
  8. Unstable angina and/or heart attack in previous month.
  9. Uncontrolled arterial hypertension.
  10. Somatic diseases in decompensation stage.
  11. Thrombosis of deep and superficial veins of the lower extremities
  12. The presence of left-handedness in the patient according to the Edinburgh manual asymmetry questionnaire
  13. Alcohol abuse, medical marijuana use or soft drug abuse within the 12 months prior to the Inclusion Visit.
  14. Any medical condition, including mental disease or epilepsy that could affect the interpretation of study results, the study procedures or patient safety.

15 Pregnancy. 16. Lactation.

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    MT in early recovery period of IS

    Patients in early recovery period of IS receive a course of rehabilitation with multimodal correction using BFB-stabilometric training, cognitive-motor training in a virtual environment (VR), functional individually programmed stimulation of antagonist muscles of the lower limb (FES), subject-manipulative activity training to restore fine movements of the hand on a glove simulator "SensoRehab", if moderate paresis of the upper limb - the neurointerface "Exokist-3" with EEG registration.

    Other: Multimodal technology (MT)

  • Experimental
    MT in late recovery period of IS

    Patients in late recovery period of IS receive a course of rehabilitation with multimodal correction using BFB-stabilometric training, cognitive-motor training in a virtual environment (VR), functional individually programmed stimulation of antagonist muscles of the lower limb (FES), subject-manipulative activity training to restore fine movements of the hand on a glove simulator "SensoRehab", if moderate paresis of the upper limb - the neurointerface "Exokist-3" with EEG registration.

    Other: Multimodal technology (MT)

  • Active comparator
    No MT Intervention: Conventional IS rehabilitation

    Patients in early and late recovery period of IS recieve conventional complex rehabilitation: kinesiotherapy, physiotherapy, occupational therapy.

    Other: Conventional rehabilitation (CR)

Interventions

  • OtherMultimodal technology (MT)

    Patients will receive a course of rehabilitation with multimodal correction using BOS-stabilometric training, cognitive-motor training with double and triple tasks once a day for the affected hand, virtual reality, functional individually programmed stimulation of antagonist muscles of the lower limb (FES), subject-manipulative activity training to restore fine movements of the hand on a glove simulator "SensoRehab", in moderate paresis of the upper limb, the neurointerface "Exokist-3" with EEG registration will be used. The program for IS patients includes 15 sessions with the MT: 15-30 minutes every method 2-3 times a week, 5-8 weeks.The total duration of one procedure is 2-3 hours.

  • OtherConventional rehabilitation (CR)

    The patients will recieve Conventional rehabilitation technology (physiotherapy, kinesiotherapy, occupational therapy. The program for IS patients includes 15 sessions with the CR: 15-30 minutes every method 2-3 times a week, 5-8 weeks.The total duration of one procedure is 2-3 hours.

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Upper Extremity Scale (FMA-UE) dynamic

    The FMA UE Scale comprises 33 items, each scored on a scale of0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. It is free, requires only household items fortesting, and takes up to 30 minutes to administer. Changes in sections A-D of the FMA-UE Scale by 7 points or more are considered as efficacy.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  2. Action Research Arm Test (ARAT) Scale dynamic

    The Action Research Arm Test (ARAT) is a 19 item observational measures. Items comprising the ARAT are categorized into four subscales (grasp, grip, pinch and gross movement) and arranged in order of decreasing difficulty, with the most difficult task examined first, followed by the least difficult task. Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally). Changes in the total ARAT Scale score by 4 points or more more are considered as efficacy.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  3. Change from Baseline in 10 Metre Walk Test

    The individual walks without assistance for 10 meters, with the time measured for the intermediate 6 meters to allow for acceleration and deceleration. The total time taken to ambulate 6 meters is recorded Timing starts when the toes pass the 2-meter mark Timing stops when the toes pass the 8-meter mark

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  4. Change from Baseline in Tinetti test

    The Tinetti-test is used to assess the gait and balance, perception of balance and stability during activities of daily living.The Tinetti test has a gait score and a balance score. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. The lower the score on the Tinetti test, the higher the risk of falling.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  5. Changes in cognitive status

    Assesment by the Montreal Cognitive Assessment scale (МоСА). MoCA is scored out of 30. A cut-off score of 26 signifies mild cognitive impairment.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  6. Change from Baseline of Presence and severity of depression and anxiety

    The Hospital Anxiety and Depression Scale (HADS). Changes in HADS anxiety and depression scores.The HADS is a fourteen item scale that generates: Seven of the items relate to anxiety and seven relate to depression.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.8-10 - points subclinically expressed anxiety / depression 11 points and above - clinically expressed anxiety / depression.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  7. Restoration of CNS function

    Concentration of human brain neurotrophic factor (BDNF) in the blood serum of patients by solid-phase enzyme immunoassay

    Time frame: Baseline, day 15 of MT

Secondary outcomes

  1. Percentage of correctly performed tasks

    percentage of correctly performed tasks while training

    Time frame: Baseline, day 7, day 15

  2. change in the paresis degree ин the 6-point Medical Research Council Scale for assessing muscle strength: MRCS

    The 6-point Medical Research Council Scale for assessing. The patient's effort is graded on a scale of 0-5. Grade 5: Muscle contracts normally against full resistance.Grade 0: No movement is observed. Grade 4 - light paresis. Grade 3 - moderate paresis. Grades 1-2 - severe paresis. The best result is 5, deterioration - a decrease in the indicator on the scale

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  3. Changes in spasticity severity

    Modified Ashworth Scale: MAS (0 to 4 points). Scoring: 0 No increase in tone (the best point); 4 limb rigid in flexion or extension (the worse outcome)

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  4. Changes in level of impairment or dependence in daily life

    Barthel Index.The Barthel Scale/Index (BI) is an ordinal scale used to measure performance in activities of daily living (ADL). Ten variables describing ADL and mobility are scored, a higher number being a reflection of greater ability to function independently following hospital discharge.Each item is rated in terms of whether the patient can perform the task independently, with some assistance, or is dependent on help based on observation (0=unable, 1=needs help, 2=independent). The final score is x 5 to get a number on a 100 point score. Proposed guidelines for interpreting Barthel scores are that scores of 0-20 indicate "total" dependency, 21-60 indicate "severe" dependency, 61-90 indicate "moderate" dependency, and 91-99 indicates "slight" dependency.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  5. Changes of Life quality assessment

    European Quality of Life Questionnaire EuroQol EQ-5D-5L (version 1.0, 2011 in combination with the visual analogue scale). Health State: The respondent classifies his or her prevailing state of health by selecting one of three different levels of problem severity within each of five health domains. The levels are none, moderate and severe/extreme (coded 1 through 3, respectively), whilst the domains are mobility, capacity for self-care, conduct of usual activities, pain/discomfort and anxiety/depression, ordered as such. Evaluation: The respondent then evaluates his or her health using a visual analogue scale (VAS). This is a vertical, calibrated, line, bounded at 0 ("worst imaginable health state") and at 100 ("best imaginable health state"). Respondents indicate where they perceive their present state of health to lie, relative to these anchors.

    Time frame: Baseline, day 7, day 15 of MT and 6 weeks after completing training

  6. Canges in Rehabilitation routing scale.

    The rehabilitation Routing Scale (SRM), developed by the Ministry of Health of Russia has six points: 1. The absence of significant disorders of vital activity, despite the existing symptoms of the disease 2. Slight restriction of vital activity 3. Restriction of vital activity, moderate in its severity 4. Pronounced restriction of vital activity 5. Gross violation of vital processes 6. Violation of vital activity of extreme severity An improvement is considered to be a decrease in the score on the scale.

    Time frame: Baseline, day 15 of MT and 6 weeks after completing training

  7. Changes by international scale of functioning, disability and health (ISF)

    A generic qualifier scale can be used to record the extent of the problem for each identified impairment, activity limitation and participation restriction. Environmental factors can also be qualified as either barriers or facilitators. Improvement - reduction of the qualifier's score in the selected domain

    Time frame: Baseline, day 15 of MT and 6 weeks after completing training

Other outcomes

  1. Number of participants with abnormal electrocardiogram (ECG) readings

    Cases of ECG deviations during the MT session are taken into account (for example, ST segment changes, occurrence of arrhythmia, QT Interval)

    Time frame: Baseline, day 1-15 of MT

  2. Number of participants with abnormal electroencephalogram (EEG) readings

    Cases of ECG deviations during the MT session are taken into account (paroxysmal activity)

    Time frame: Baseline, day 15 of MT

07

Study locations

1 site
  • Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine, branch 7
    Moscow, 105120, Russian Federation
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05391919
Lead sponsor
Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
Collaborators
Moscow Government
Responsible party
Sponsor
First posted
May 26, 2022
Start date
Mar 17, 2022
Primary completion
May 31, 2023
Completion
May 31, 2023
Last update
Sep 14, 2023

Study contacts

Elena V Kostenko, PhD, D. Sс (Medicine)
study director · Moscow scientific and practical center of medical rehabilitation, restorative and sports medicine of the Department of health of the city of Moscow, branch 7;

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion